Wary pharma: AstraZeneca sours on UK

More inflation numbers, more jabs by President Donald Trump at Jay Powell, the Federal Reserve chairman. We ask what the Fed is doing, should be doing and is being pressured to do. Six years after the official Brexit divorce, we count the costs and ask what making-up is now possi ...  Show more

From Argentinian beef to German cars, a freshly inked deal between the EU and a bloc of South American countries should ease trade barriers—and is a sign of global trade’s topsy-turvy time. Foreigner-bashing is politically fashionable in Japan, but focuses on the wrong problems. ...  Show more

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  Show more

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  Show more

With China as its new rival, America is reviving old wartime facilities across the Pacific. Our correspondent visits an abandoned airfield that has been given new life. The outlook for climate technology is surprisingly bright. And why the universe of Hello Kitty keeps expanding. ...  Show more

Since Donald Trump announced punishing tariffs on “Liberation Day” last week, stock markets have fallen and governments and businesses scrambled to respond. Our correspondent discusses the impact on the global economy. Do personalised diets really improve gut health (9:16)? And g ...  Show more